Cohorte Nantaise de Maladies Inflammatoires Chroniques Intestinales
Status: Recruiting
Location: See all (3) locations...
Intervention Type: Other
Study Type: Observational
SUMMARY
The CELESTE cohort will be a three-center prospective cohort associated with the creation of a biobank including Inflammatory Bowel Diseases (IBD) patients with active disease
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Patients over 18 years of age;
• Patients with an established diagnosis of IBD: CD, UC, unclassified IBD or refractory chronic pouchitis;
• Patients with active disease requiring surgery or endoscopy, whether performed at diagnosis or prior to initiation of new therapy;
• Patients who have given written consent to participate in the study and to keep biological samples for research purposes
Locations
Other Locations
France
CHU de Nantes
RECRUITING
Nantes
Clinique Jules Verne
NOT_YET_RECRUITING
Nantes
Hopital Privé du Confluent
NOT_YET_RECRUITING
Nantes
Contact Information
Primary
Catherine Le Berre, MD
catherine.leberre@chu-nantes.fr
+33240083152
Time Frame
Start Date: 2025-02-04
Estimated Completion Date: 2031-02
Participants
Target number of participants: 360
Treatments
Patients
Patients of both sexes, over 18 years of age, with an established diagnosis of IBD (Crohn's desease, ulcerative colitis, unclassified IBD or chronic pouchitis) will be eligible for inclusion in a consultation to schedule surgery or colonoscopy for disease relapse (at diagnosis or prior to initiation of treatment), irrespective of treatment received
Related Therapeutic Areas
Sponsors
Leads: Nantes University Hospital